(Q46329536)

21 December 2017

title

Efficacy of a combination of praziquantel and artesunate in the treatment of urinary schistosomiasis in Nigeria (English)

1 reference

21 December 2017

0 references

0 references

0 references

urinary schistosomiasis

1 reference

1 reference

P C Inyang-Etoh

1

1 reference

21 December 2017

G C Ejezie

series ordinal

2

1 reference

21 December 2017

M F Useh

series ordinal

3

1 reference

21 December 2017

E C Inyang-Etoh

series ordinal

4

1 reference

21 December 2017

language of work or name

1 reference

5 October 2008

1 reference

21 December 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

published in

1 reference

21 December 2017

volume

103

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

page(s)

38-44

1 reference

21 December 2017

Persistence of Schistosoma haematobium infection despite multiple courses of therapy with praziquantel

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.08.002

The effect of different treatment regimens on the epidemiology of seasonally transmitted Schistosoma haematobium infections in four villages in the Senegal River Basin, Senegal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.08.002

Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.08.002

Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.08.002

Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.08.002

Efficacy of artesunate in the treatment of urinary schistosomiasis, in an endemic community in Nigeria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.08.002

Modification of behaviour and attitude in the control of schistosomiasis. 1. Observations on water-contact patterns and perception of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.08.002

Day-to-day variation of egg output and schistosome circulating antigens in urine of Schistosoma haematobium-infected school children from Gabon and follow-up after chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.08.002

School-based schistosomiasis control programmes: a comparative study on the prevalence and intensity of urinary schistosomiasis among Nigerian school-age children in and out of school.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.08.002

Schistosoma mansoni: chemotherapy of infections of different ages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.08.002

Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.08.002

Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.08.002

Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.08.002

Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.08.002

Praziquantel-induced tegumental damage in vitro is diminished in schistosomes derived from praziquantel-resistant infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.08.002

10.1016/J.TRSTMH.2008.08.002

7 January 2021

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

18838149

1 reference

21 December 2017